by Dr. John McKeon
Airmid was delighted to participate in the Enterprise Ireland St. Patrick’s Day Economic Program 2025 in D.C.; an event that reinforced Ireland’s strategic position as a global leader in MedTech, life sciences, and innovation-driven industries
The program provided a unique platform for Irish companies to explore opportunities for scaling in the U.S. market, securing investment, and expanding international partnerships.
One of the highlights of the day was the Inter-Agency Business Leaders Lunch, where An Taoiseach, Micheál Martin, addressed industry leaders, investors, and policymakers, emphasizing Ireland’s continued commitment to fostering innovation, research, and business growth on the world stage. His keynote reinforced the importance of Ireland’s role as a trusted partner for global expansion in MedTech, life sciences, and advanced technologies.
Airmid were delighted to have in attendance Matt Hardwick, renown GLP expert, microbiological thought leader and a key representative for Airmid in the US.
A Deep Dive into Scaling and Investment for MedTech and Life Sciences
The Scaling and Investment Summit focused on how Irish companies can leverage the U.S. market for growth, access venture and private capital, and navigate mergers and acquisitions (M&A) for strategic expansion. The event featured leading CEOs, investors, and industry experts, sharing insights into the pathways for scaling globally.
Key Takeaways from the Event:
Access to Capital for Scaling
A panel discussion featuring leaders from venture capital and private equity explored the critical role of funding in scaling MedTech and life sciences businesses. Panelists included:
Kieran McLoughlin; Co-Founder and managing partner of Venture Wave
Alan Merriman, Founder, Elkstone – Discussing the importance of patient capital and long-term investment strategies.
John Feeney, CEO, Corporate & Commercial Division, Bank of Ireland – Offering insights into financial structures that support scaling companies.
Brian O’Connor, ISIF – Highlighting government-backed investment strategies for growth-stage businesses.
M&A Strategies for Growth
Many successful MedTech and life sciences companies scale through strategic partnerships, mergers, or acquisitions. The M&A panel featured:
Robert Carpenter, CEO, Granite Digital
Ciaran Gorman, CFO & Co-Founder, BevCraft
Prodieco – Sharing insights on successful international expansions.
The Role of Strategic Communications in Scaling Globally
The importance of navigating the U.S. regulatory, political, and economic landscape was discussed by:
Ben English, US-Ireland Partnership
Kate McNulty, Covington & Burling LLP
Anthony Campau, Partner, Clark Hill
Their expertise shed light on how Irish MedTech and life sciences firms can position themselves effectively in the U.S. market, manage regulatory challenges, and optimize their messaging for stakeholders.
Ireland: A Global Hub for MedTech and Life Sciences
Ireland has firmly established itself as one of the world’s leading MedTech and life sciences ecosystems, with over 450 companies operating in the sector, including 14 of the world’s top 15 MedTech multinationals. The Enterprise Ireland St. Patrick’s Economic Program further highlighted Ireland’s unique strengths in research, innovation, and regulatory science, which are essential for companies aiming to scale internationally.
Airmid Healthgroup is proud to be part of this thriving ecosystem. Our work in scientific validation, regulatory compliance, and product testing helps MedTech companies bridge the gap between research and real-world application, ensuring their innovations meet the highest standards for global markets.
With strong government backing, world-class research institutions, and a commitment to fostering high-growth industries, Ireland remains a launchpad for companies looking to scale, innovate, and succeed on the world stage.
The insights and connections gained at this event reaffirmed our commitment to driving innovation in MedTech and life sciences. As the industry evolves, Airmid Healthgroup looks forward to supporting the next generation of groundbreaking health technologies—helping companies navigate complex regulatory landscapes, validate their products, and scale successfully in global markets.
Related External Links
https://www.idaireland.com/explore-your-sector/business-sectors/medtech
https://www.researchireland.ie
Related Services
https://airmidhealthgroup.com/contract-research-2.html
https://airmidhealthgroup.com/policy-and-government-2.html
Related Blogs
Key Word Phrases
Scaling MedTech and life sciences; Ireland’s MedTech innovation hub; Venture capital for MedTech startups; Mergers and acquisitions in life sciences; Regulatory compliance for MedTech; Strategic growth in healthcare technology; Investment opportunities in MedTech; Science-driven product validation; Ireland’s leadership in medical innovation
Key Word Tags
#MedTech
#LifeSciences
#ScalingBusiness
#IrelandInnovation
#VentureCapital
#HealthcareTech
#RegulatoryCompliance
#BusinessExpansion
#InvestmentOpportunities
#GlobalGrowth
Are you a medtech innovator looking to enhance the safety and performance of your products?
Contact the Airmid Health Group team today to learn more about the independent testing process and how it can enhance your product’s credibility in the market.
